The effect of low-dose marine n-3 fatty acids on the biosynthesis of pro-inflammatory 5-lipoxygenase pathway metabolites in overweight subjects: A randomized controlled trial

Marine n-3 polyunsaturated fatty acids (PUFA) have a variety of anti-inflammatory properties. This study evaluated the effect of n-3 PUFA in a low, but recommended cardioprotective dosage on the formation of 5-lipoxygenase pathway metabolites in overweight subjects. Fifty subjects were randomized to...

Full description

Saved in:
Bibliographic Details
Published inProstaglandins, leukotrienes and essential fatty acids Vol. 87; no. 1; pp. 43 - 48
Main Authors Nielsen, M.S., Gammelmark, A., Madsen, T., Obel, T., Aardestrup, I., Schmidt, E.B.
Format Journal Article
LanguageEnglish
Published Scotland Elsevier Ltd 01.07.2012
Subjects
Online AccessGet full text
ISSN0952-3278
1532-2823
1532-2823
DOI10.1016/j.plefa.2012.05.009

Cover

Loading…
More Information
Summary:Marine n-3 polyunsaturated fatty acids (PUFA) have a variety of anti-inflammatory properties. This study evaluated the effect of n-3 PUFA in a low, but recommended cardioprotective dosage on the formation of 5-lipoxygenase pathway metabolites in overweight subjects. Fifty subjects were randomized to 1.1g of n-3 PUFA or olive oil for 6 weeks. Leukotriene B4 formation decreased by 14% in the n-3 PUFA group which proved to be significant within the group (p=0.005) but not between groups (p=0.25). The formation of 5-hydroxyeicosatetraenoic acid (5-HETE) did not differ significantly between the groups. In the n-3 PUFA group, both 5-hydroxyeicosapentaenoic (5-HEPE) acid and leukotriene B5 increased significantly compared to the control group (p<0.001). In conclusion, we did not observe any significant net anti-inflammatory effect on the 5-lipoxygenase pathway from a daily supplement of 1.1g marine n-3 PUFA for 6 weeks.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
ISSN:0952-3278
1532-2823
1532-2823
DOI:10.1016/j.plefa.2012.05.009